Best Practices for Adolescent Substance Use Disorder Treatment:
From Psychotherapy to Infrastructure
Accredited for 1.0 AMA PRA Category 1 Credits™
Friday, July 24, 2026
11 a.m. - 12 Noon ET
Members: FREE
Nonmembers: $75
Registration required.
Program description:
This session will cover topics related to adolescent substance use prevention, recognition, screening, and treatment options. It will also highlight local resources available to Indiana clinicians, as well as an IU Health initiative aimed at increasing screening and access to brief interventions for adolescent substance use.
Additional training on this topic is available through a two-part, online, asynchronous course offered by Indiana University School of Medicine Continuing Education.
Objectives:
At the end of this webinar, attendees will be able to:
- Identify 4-5 evidence supported modalities that improve outcomes for adolescents with substance use disorders.
- Describe the array of levels of care needed for substance use disorder care and why they are in short supply.
- Evaluate novel treatment infrastructure designed to meet the needs of adolescents with substance use disorders.
Speaker:
Leslie Hulvershorn, MD
Indiana University School of Medicine
Chair, Department of Psychiatry
CME INFORMATION
Designation Statement: The Indiana State Medical Association (ISMA) designates this live webinar for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Statement: The Indiana State Medical Association (ISMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Disclosure Policy: In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by the ISMA must demonstrate balance, independence, objectivity and scientific rigor. Prior to the activity, all faculty, authors, editors and planning committee members participating in an ISMA-sponsored activity are required to disclose to attendees any relevant financial relationships with an “ineligible company” whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure Statement: No member of the CME Planning Committee or our speaker have any relevant financial relationships to disclose.
If you have questions, contact ISMA Continuing Medical Education staff at 800-257-4762 or seminars@ismanet.org.
REGISTRATION DEADLINE: July 24 at 10:30 a.m. ET